Navigation Links
Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties
Date:7/3/2008

MINNEAPOLIS, July 3 /PRNewswire/ -- The Eniva Research Group has released results from aboratory testing by the world-famous Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva Health Supplement VIBE(R) possessed DNA protective anti-mutagenic activity for human cells. This third party testing was performed as part of an ongoing investigative effort to further identify mechanisms by which the Eniva VIBE nutraceutical impacts human health.

Chief Scientific Officer for Eniva Corporation, Dr. Benjamin Baechler, stated, "While these results are tremendously exciting and give us insight into one of the mechanisms of action of the VIBE nutraceutical, we must be careful not to generalize these results beyond the study findings. What we can say for certain is these results further demonstrate the ability of the VIBE nutraceutical to help support healthy and normal functioning of human cells, even under very stressful physiologic situations."

The research design consisted of culturing human cells with and without the VIBE nutraceutical and then exposing these human cells to a well known DNA mutagen-ultraviolet radiation. After a period of time, the human skin cells were then obtained and examined for specific damage to their DNA. Results were compared between the human cells supported by VIBE in their growth medium and those without it. The results demonstrated an extremely statistically significant decrease in DNA damage in those human cells which were supported with the VIBE nutraceutical (p-value < 0.001).

The exact laboratory technique used was the COMET assay, otherwise known as Single-Cell Gel Electrophoresis (SCGE), which is a very sensitive and well-known peer accepted laboratory method for assessing damage to cellular DNA. The COMET assay is widely used to assess DNA damage in cancer research, environmental toxicology and radiation biology. After mutagen exposure, cells are embedded in agarose gel on a microscope slide, lysed, electrophoresed, and then stained with fluorescent DNA binding dye. Damaged DNA migrates during the process, forming a shape often described as a "comet." The specific pattern is then automatically quantified through laser assisted computer analysis. Through specific algorithms, DNA damage can then be quantified and trends evaluated.

These results are part of an intensive initiative by the Eniva Corporation to further explore the mechanism of action behind their nutraceutical products. Chairman of Eniva Corporation, Andrew Baechler, commented, "This result further identifies and separates Eniva as a leader in providing science-based dietary solutions. We are very enthusiastic about the findings and are very grateful to our collaborators at the Linus Pauling Micronutrient Research Institute."

Eniva Corporation is a manufacturer and global marketer of high quality, science-based dietary supplements known as nutraceuticals. It carries a product line of over 75 wellness products, ranging from cardiovascular to general health and wellness. The corporation recently celebrated its tenth year anniversary at its world headquarters in Anoka, Minnesota. More

information on this topic and the actual testing data can be found at http://www.enivanutraceutics.com.


'/>"/>
SOURCE Eniva
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
4. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
5. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
6. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
7. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
8. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... The BMT ... the Center for International Blood & Marrow Transplant Research (CIBMTR) will take place ... , The combined scientific sessions offer investigators, clinicians, laboratory technicians, clinical research ...
(Date:2/17/2017)... February 17, 2017 According ... by Product (Consumables, Service), Type (Safety, Efficacy, Validation), ... Drug Discovery and Development, Disease-Risk) - Global Forecast ... projected to reach USD 53.34 Billion by 2021 ... a CAGR of 13.8% during the forecast period ...
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics (AMA), ... maker of unmanned aircraft systems (UAS), are launching a joint program to promote ... and support educational outreach efforts. , AMA and DJI will collaborate on other ...
(Date:2/16/2017)... ... , ... Avomeen & MichBio will be hosting a BioMixer next week Thursday, ... Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are a casual, members-only ... with peers, make new connections and talk bio biz. , Cost:, ...
Breaking Biology Technology:
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):